• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Dissection of the TNM staging classification for nasopharyngeal cancer - past, present, and future.鼻咽癌TNM分期分类剖析——过去、现在与未来
Cancer Biol Med. 2025 Jun 26;22(7):715-21. doi: 10.20892/j.issn.2095-3941.2025.0170.
2
A Proposal for HPV-Associated Oropharyngeal Carcinoma in the Ninth Edition Clinical TNM Classification.关于第九版临床TNM分类中HPV相关口咽癌的提案。
JAMA Otolaryngol Head Neck Surg. 2025 May 8. doi: 10.1001/jamaoto.2025.0848.
3
The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification.将治疗前血浆 Epstein-Barr 病毒 DNA 纳入第八版鼻咽癌 TNM 分期分类中。
Int J Cancer. 2019 Apr 1;144(7):1713-1722. doi: 10.1002/ijc.31856. Epub 2018 Dec 24.
4
The International Association for the Study of Lung Cancer Staging Project: The Database and Proposal for the Revision of the Staging of Pulmonary Neuroendocrine Carcinoma in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer.国际肺癌研究协会分期项目：数据库及对即将出版的第九版肺癌TNM分类中肺神经内分泌癌分期修订的建议。
J Thorac Oncol. 2025 Jan 24. doi: 10.1016/j.jtho.2025.01.013.
5
Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.IB 期非小细胞肺癌患者应接受辅助化疗吗？第 8 版和第 7 版 AJCC TNM 分期系统对 IB 期患者的生存比较。
J Cancer Res Clin Oncol. 2019 Feb;145(2):463-469. doi: 10.1007/s00432-018-2801-7. Epub 2018 Nov 24.
6
Differences Between the 8th and 9th Editions of the TNM Staging System in Predicting Mortality in Non-Small Cell Lung Cancer Patients Staged with EBUS.第八版与第九版TNM分期系统在预测经超声支气管镜检查分期的非小细胞肺癌患者死亡率方面的差异
Diagnostics (Basel). 2025 Jun 20;15(13):1570. doi: 10.3390/diagnostics15131570.
7
Staging of oral cavity cancer in the 8th edition of the TNM classification: The role of computed tomography in the assessment of depth of invasion and extranodal extension.《TNM 分类第 8 版中口腔癌的分期：计算机断层扫描在评估浸润深度和结外扩展中的作用》
Braz J Otorhinolaryngol. 2025 Jul;91 Suppl 1(Suppl 1):101645. doi: 10.1016/j.bjorl.2025.101645. Epub 2025 Jun 4.
8
Cancer of unknown primary site and TNM staging: a new paradigm for patient management.原发部位不明的癌症与TNM分期：患者管理的新范式
Ann Oncol. 2025 Jul 21. doi: 10.1016/j.annonc.2025.07.007.
9
The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma. A critical revision of the 1987 TNM classification.肿瘤扩散、分级及生长模式作为膀胱癌形态学预测参数的价值。对1987年TNM分类的批判性修订。
J Cancer Res Clin Oncol. 1993;119(10):578-93. doi: 10.1007/BF01372721.
10
Validation of the 9th edition of the TNM staging system for limited-stage small cell lung cancer after Resection: A multicenter study.第9版TNM分期系统对局限性小细胞肺癌切除术后的验证：一项多中心研究。
Lung Cancer. 2025 Feb;200:108085. doi: 10.1016/j.lungcan.2025.108085. Epub 2025 Jan 12.

本文引用的文献

1
Ninth Version of the AJCC and UICC Nasopharyngeal Cancer TNM Staging Classification.美国癌症联合委员会（AJCC）和国际抗癌联盟（UICC）鼻咽癌TNM分期分类第九版。
JAMA Oncol. 2024 Oct 10;10(12):1627-35. doi: 10.1001/jamaoncol.2024.4354.
2
Criteria for the diagnosis of extranodal extension detected on radiological imaging in head and neck cancer: Head and Neck Cancer International Group consensus recommendations.头颈部癌症中影像学检查发现的结外侵犯的诊断标准：头颈部癌症国际协作组共识推荐。
Lancet Oncol. 2024 Jul;25(7):e297-e307. doi: 10.1016/S1470-2045(24)00066-4.
3
Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma.改良第 8 版 EBV 相关鼻咽癌 TNM 分期。
Cancer Cell. 2024 Mar 11;42(3):464-473.e3. doi: 10.1016/j.ccell.2023.12.020. Epub 2024 Jan 18.
4
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial.吉西他滨和顺铂诱导化疗治疗鼻咽癌的最终总生存分析：一项多中心、随机 III 期试验。
J Clin Oncol. 2022 Aug 1;40(22):2420-2425. doi: 10.1200/JCO.22.00327. Epub 2022 Jun 16.
5
The global, regional, national burden of nasopharyngeal cancer and its attributable risk factors (1990-2019) and predictions to 2035.全球、区域、国家鼻咽癌负担及其归因风险因素（1990-2019 年），以及对 2035 年的预测。
Cancer Med. 2022 Nov;11(22):4310-4320. doi: 10.1002/cam4.4783. Epub 2022 Apr 27.
6
Prognostic Factors for Overall Survival in Nasopharyngeal Cancer and Implication for TNM Staging by UICC: A Systematic Review of the Literature.鼻咽癌总生存的预后因素及国际抗癌联盟（UICC）TNM分期的意义：文献系统综述
Front Oncol. 2021 Sep 2;11:703995. doi: 10.3389/fonc.2021.703995. eCollection 2021.
7
Local treatment of metastases plus systemic chemotherapy on overall survival of patients with metastatic nasopharyngeal carcinoma.局部治疗联合全身化疗对转移性鼻咽癌患者总生存期的影响。
Head Neck. 2021 Aug;43(8):2423-2433. doi: 10.1002/hed.26706. Epub 2021 May 3.
8
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline.《CSCO/ASCO 鼻咽癌临床诊疗指南》：放化疗用于局部晚期鼻咽癌的根治性治疗
J Clin Oncol. 2021 Mar 1;39(7):840-859. doi: 10.1200/JCO.20.03237. Epub 2021 Jan 6.
9
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.鼻咽癌：ESMO-EURACAN诊断、治疗及随访临床实践指南
Ann Oncol. 2021 Apr;32(4):452-465. doi: 10.1016/j.annonc.2020.12.007. Epub 2020 Dec 25.
10
Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial.局部区域放射治疗联合化疗对比单纯化疗治疗初诊转移性鼻咽癌的疗效和安全性：一项多中心 3 期随机临床试验。
JAMA Oncol. 2020 Sep 1;6(9):1345-1352. doi: 10.1001/jamaoncol.2020.1808.

Dissection of the TNM staging classification for nasopharyngeal cancer - past, present, and future.

作者信息

Liu Qin, Lee Anne W M

机构信息

Department of Clinical Oncology, The University of Hong Kong, Hong Kong 999077, Hong Kong, China.

Clinical Oncology Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518000, China.

出版信息

Cancer Biol Med. 2025 Jun 26;22(7):715-21. doi: 10.20892/j.issn.2095-3941.2025.0170.

DOI:10.20892/j.issn.2095-3941.2025.0170
PMID:40574725
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12302267/
Abstract
摘要